Downregulated mRNAs were mainly enriched in prostate cancer, transcriptional misregulation in cancer, melanoma, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance, and microRNAs in cancer (Supplement Table 4) (Figure 2). This evidence concerns the gene EGFR and prostate carcinoma.